Trial
NCT02144155
Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
—
Condition
Schizophrenia
Intervention
Oxytocin: 24IU - 168 IU
Why stopped
Break in funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-09